Cargando…
Induction of differentiation of the acute myeloid leukemia cell line (HL-60) by a securinine dimer
Differentiation therapy has been successfully applied clinically in cases of acute promyelocytic leukemia (APL), but few differentiation-induction agents other than all-trans retinoic acid (ATRA) have been discovered clinically. Based on our previously reported neuritogenic differentiation activity...
Autores principales: | Hou, Wen, Wang, Zhen-Ya, Lin, Jing, Chen, Wei-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665178/ https://www.ncbi.nlm.nih.gov/pubmed/33298839 http://dx.doi.org/10.1038/s41420-020-00354-3 |
Ejemplares similares
-
Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML
por: Gupta, Kalpana, et al.
Publicado: (2011) -
Novel bivalent securinine mimetics as topoisomerase I inhibitors
por: Hou, Wen, et al.
Publicado: (2017) -
Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells
por: Huang, Qinwan, et al.
Publicado: (2019) -
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60
Publicado: (1984) -
An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects
por: Yamasaki, Amanda E., et al.
Publicado: (2020)